Covered recipient · General Payments record
KRISTINA MATKOWSKYJ
Allopathic & Osteopathic Physicians Pathology Clinical Pathology/Laboratory Medicine
General Payments · PY2019–2024
$38,317.36
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $20,066.49 | 14 |
| Food and Beverage | $263.52 | 6 |
| Travel and Lodging | $232.00 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Promega Corporation | $7,200.00 | 4 |
| Merck Sharp & Dohme Corporation | $5,621.87 | 7 |
| Daiichi Sankyo Inc. | $5,445.00 | 4 |
| Amgen Inc. | $2,107.74 | 3 |
| Astellas Pharma US Inc | $187.40 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201920222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $735.74 | 06/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117622586 | CMS |
| Amgen Inc. | $686.00 | 10/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117622588 | CMS |
| Amgen Inc. | $686.00 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117622590 | CMS |
| Astellas Pharma US Inc | $4.31 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139358335 | CMS |
| Astellas Pharma US Inc | $81.24 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139369109 | CMS |
| Astellas Pharma US Inc | $48.60 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139369167 | CMS |
| Astellas Pharma US Inc | $53.25 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139368573 | CMS |
| Daiichi Sankyo Inc. | $1,512.50 | 04/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089453552 | CMS |
| Daiichi Sankyo Inc. | $605.00 | 04/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089453554 | CMS |
| Daiichi Sankyo Inc. | $907.50 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089453556 | CMS |
| Daiichi Sankyo Inc. | $2,420.00 | 12/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089453550 | CMS |
| Merck Sharp & Dohme LLC | $22.92 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141559439 | CMS |
| Merck Sharp & Dohme LLC | $53.20 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141824967 | CMS |
| Merck Sharp & Dohme LLC | $681.25 | 06/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141653450 | CMS |
| Merck Sharp & Dohme LLC | $31.00 | 06/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1141599851 | CMS |
| Merck Sharp & Dohme LLC | $201.00 | 06/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1141599863 | CMS |
| Merck Sharp & Dohme LLC | $1,907.50 | 06/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141599867 | CMS |
| Merck Sharp & Dohme LLC | $2,725.00 | 06/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141653448 | CMS |
| Promega Corporation | $1,200.00 | 04/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1082480020 | CMS |
| Promega Corporation | $900.00 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1082480016 | CMS |
| Promega Corporation | $2,400.00 | 06/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1082480014 | CMS |
| Promega Corporation | $2,700.00 | 06/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1082480018 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.